COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.

Sydney B RossMarnie Goodwin WilsonLouise Papillon-FerlandSarah ElsayedPeter E WuKiran BattuSandra PorterBabak RashidiRobyn TamblynLouise PiloteJames DownarAndre BonniciAllen HuangTodd C LeeEmily Gibson McDonald

Published in: Journal of the American Geriatrics Society (2020)

The COVID-19 pandemic highlights the importance of medication optimization and deprescribing PIMs in older adults. By acting now to reduce polypharmacy and use of PIMs, we can better prepare this vulnerable population for inclusion in trials and, if substantiated, pharmacologic treatment or prevention of COVID-19. J Am Geriatr Soc 68:1636-1646, 2020.

Keyphrases

coronavirus disease
sars cov
physical activity
adverse drug
healthcare
respiratory syndrome coronavirus
emergency department
combination therapy